• 1. The alteration of urinary metabolomics profiles in Kashin–Beck disease in a three consecutive year study
  Yujie Ning,Sijie Chen,Feiyu Zhang,Yanli Liu,Feihong Chen,Shujin Li,Chaowei Wang,Yifan Wu,Yi Gong,Minhan Hu,Ruitian Huang,Xiong Guo,Lei Yang,Xi Wang Mol. Omics 2023 19 137
• 2. High-performance liquid chromatography in clinical and biological chemistry
  R. W. Frei,I. D. Watson,M. J. Stewart,L. F. Prescott,I. S. King,Lindsey Brown,M. Balali,P. I. Adriaenssens,P. F. Dixon,P. Lukha,N. R. Scott,C. K. Lim Proc. Anal. Div. Chem. Soc. 1979 16 289

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzazepines Dibenzazepines

2-Hydroxy Imipramine (CAS No. 303-70-8): A Comprehensive Overview

2-Hydroxy Imipramine (CAS No. 303-70-8) is a biologically active metabolite of the well-known tricyclic antidepressant Imipramine. This compound has garnered significant attention in pharmacological research due to its unique properties and potential therapeutic applications. In this article, we delve into the chemical characteristics, mechanisms of action, and current research trends surrounding 2-Hydroxy Imipramine, while also addressing common queries from researchers and healthcare professionals.

The molecular structure of 2-Hydroxy Imipramine features a hydroxyl group at the 2-position of the imipramine backbone, which significantly influences its pharmacokinetics and pharmacodynamics. This modification enhances its solubility and bioavailability compared to its parent compound, making it a subject of interest in drug development. Recent studies have explored its role in modulating neurotransmitter systems, particularly serotonin and norepinephrine, which are critical in mood regulation.

One of the most frequently searched questions about 2-Hydroxy Imipramine is its efficacy compared to Imipramine. Research indicates that while both compounds share similar mechanisms, the hydroxylated derivative may offer improved side-effect profiles and faster onset of action. This has led to investigations into its potential use in treatment-resistant depression, a hot topic in modern psychiatry.

Another area of interest is the metabolic pathways of 2-Hydroxy Imipramine. The compound is primarily metabolized in the liver via cytochrome P450 enzymes, particularly CYP2D6. Genetic polymorphisms in these enzymes can lead to variations in drug response, a concern often raised in pharmacogenomics discussions. Understanding these pathways is crucial for personalized medicine approaches, which are increasingly demanded by patients and clinicians alike.

In addition to its antidepressant properties, 2-Hydroxy Imipramine has shown promise in other neurological applications. Preliminary studies suggest it may have neuroprotective effects, potentially useful in conditions like Parkinson's disease and Alzheimer's disease. These findings align with the growing public interest in neurodegenerative disease research and alternative therapies.

The synthesis of 2-Hydroxy Imipramine typically involves the hydroxylation of Imipramine using specific chemical or enzymatic methods. Researchers often search for optimized synthesis protocols to improve yield and purity, reflecting the compound's importance in both academic and industrial settings. Recent advancements in green chemistry have also spurred interest in more sustainable production methods.

Quality control and analytical methods for 2-Hydroxy Imipramine are another common search topic. High-performance liquid chromatography (HPLC) and mass spectrometry are frequently employed for its identification and quantification in various matrices. These techniques are crucial for ensuring the consistency and safety of pharmaceutical preparations containing this metabolite.

From a market perspective, the demand for 2-Hydroxy Imipramine reference standards has increased steadily, driven by both research needs and regulatory requirements. Pharmaceutical companies and contract research organizations often seek high-purity samples for drug development and bioequivalence studies. This trend reflects the broader movement toward precision medicine and evidence-based therapeutics.

Environmental fate and ecotoxicology of 2-Hydroxy Imipramine have emerged as important considerations, particularly given the growing awareness of pharmaceutical pollution. Studies investigating its persistence in water systems and potential effects on aquatic organisms are becoming more prevalent, addressing concerns raised by environmental scientists and policymakers.

In conclusion, 2-Hydroxy Imipramine (CAS No. 303-70-8) represents a fascinating intersection of pharmacology, chemistry, and medicine. Its unique properties continue to inspire research across multiple disciplines, from basic science to clinical applications. As our understanding of this compound deepens, it may open new avenues for treating mental health disorders and other neurological conditions, making it a compound worth watching in the coming years.

• 1977-15-7(2-Hydroxy Desipramine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)